Rituximab in severe, treatment-refractory interstitial lung disease-Reference-Cited by-同舟云学术

Rituximab in severe, treatment-refractory interstitial lung disease

Published:2013-11-29 Issue:3 Volume:19 Page:353-359
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Keir Gregory J.¹²,Maher Toby M.¹,Ming Damien¹,Abdullah Reza¹,de Lauretis Angelo³,Wickremasinghe M.⁴,Nicholson Andrew G.¹,Hansell David M.¹,Wells Athol U.¹,Renzoni Elisabetta A.¹

Affiliation:

1. Royal Brompton Hospital; London UK

2. Princess Alexandra Hospital; Brisbane Queensland Australia

3. Department of Pneumonology; Carlo Poma Hospital; Mantua Italy

4. St Mary's Hospital; London UK

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12214/fullpdf

Reference35 articles.

1. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma;Hoyles;Arthritis Rheum.,2006

2. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N. Engl. J. Med.,2006

3. Immunopathology, diagnosis, and management of hypersensitivity pneumonitis;Selman;Semin. Respir. Crit. Care Med.,2012

4. Use of intravenous cyclophosphamide in known or suspected advanced non-specific interstitial pneumonia;Corte;Sarcoidosis Vasc. Diffuse Lung Dis.,2009

5. Rituximab treatment of the anti-synthetase syndrome: a retrospective case series;Sem;Rheumatology (Oxford),2009

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic-Sclerosis-Related Interstitial Lung Disease: A Review of the Literature and Recommended Approach for Clinical Pharmacists;Annals of Pharmacotherapy;2023-12-14

2. Myositis-associated interstitial lung disease;Revista Colombiana de Reumatología;2023-11

3. Renal function during long-term therapy with rituximab in patients with systemic sclerosis;Modern Rheumatology Journal;2023-10-17

4. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases;2023-09-25

5. Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis;RMD Open;2023-07